The Immunomodulatory and Biomimetic Materials (IMBM) Lab develops material-based technologies to address critical health challenges and enable advanced bioengineering models. Our approach involves the rational design of supramolecular synthetic materials composed of naturally occurring building blocks (such as peptides, sugars, and lipids) that can interact with biological systems and create modular microenvironments. We employ a multi-scale strategy, spanning from molecular design to control nanostructure and bulk material properties, ultimately influencing the biological response to our materials.

My research has focused on novel technologies for disease diagnosis and treatment and has spanned from early innovation through development and validation and into clinical applications. Instruments that I have invented and developed have been applied in clinical studies of cervical cancer, bladder cancer, coronary atherosclerosis, laryngeal pathology, dermatologic lesions, colonic and esophageal cancer, and diseases of the common bile duct and pancreas. 

Focusing on the interface of fluid dynamics and epidemiology, The Fluid Dynamics of Disease Transmission Laboratory, within the Fluids and Health Network, led by Prof. Bourouiba, aims to elucidate the fundamental physical mechanisms shaping the transmission dynamics of pathogens in human, animal, and plant populations where drops, bubbles, multiphase and complex flows are at the core, in addition to broader questions at the intersection of health, broadly defined, and fluid physics.